High expression of let-7, miRNAs-21, -23, and −27a has been linked with drug resistance in ovarian cancer [22], whereas miRNA-452 was shown to be significantly down-regulated in adriamycin-resistant breast cancer cells; targeting insulin-like growth factor-1 receptor (IGF-1R) [23]. The gene discussed is IGF1R; the disease is ovarian carcinoma.